Non-Hodgkin Lymphoma (NHL) is the cancer with the strongest scientific link to glyphosate — the active ingredient in Roundup — and the diagnosis at the center of the federal Roundup MDL. If you used Roundup and were diagnosed with NHL or any of its subtypes, you may be entitled to significant compensation from Monsanto and Bayer.
Non-Hodgkin Lymphoma (NHL) is a group of more than 60 distinct cancers that all start in lymphocytes — the white blood cells that drive your immune system. The disease begins when those cells develop genetic damage and start growing out of control, accumulating in lymph nodes, the spleen, the bone marrow, and other organs. The American Cancer Society estimates that more than 80,000 Americans are diagnosed with NHL each year.
NHL is divided into two big families — B-cell lymphomas (about 85% of cases) and T-cell or NK-cell lymphomas (about 15%) — and into "aggressive" (fast-growing) and "indolent" (slow-growing) types. The diagnosis driving the federal Roundup MDL is most often a B-cell NHL, with Diffuse Large B-cell Lymphoma and Follicular Lymphoma the two most common subtypes among Roundup plaintiffs.
Painless swelling of lymph nodes in the neck, armpit, or groin
Unexplained fever, drenching night sweats, and chills
Significant unintended weight loss
Persistent fatigue, weakness, or shortness of breath
Abdominal swelling or pain, chest pain, or persistent cough
Easy bruising, bleeding, or recurrent infections
If you don't see your subtype here
Roundup is linked to many forms of NHL beyond those listed. If you used Roundup and have any NHL diagnosis, contact us — Herb Borroto, M.D., J.D., personally reviews pathology reports to confirm whether your subtype fits the glyphosate-linked patterns.
The connection between Roundup and NHL is not a guess. It is supported by a coherent scientific record — agricultural cohort studies, case-control studies, meta-analyses, and the IARC monograph — and reinforced by Monsanto's own internal documents.
The World Health Organization's International Agency for Research on Cancer (IARC) reviewed the global scientific record and classified glyphosate as a Group 2A carcinogen — "probably carcinogenic to humans" — with the strongest specific link to Non-Hodgkin Lymphoma. The monograph is Volume 112 of the IARC series.
Multiple peer-reviewed case-control and cohort studies of farmers, applicators, and other heavily exposed workers have found increased rates of NHL associated with glyphosate exposure. Pooled meta-analyses have estimated approximately a 40% increase in NHL risk among individuals with the highest cumulative Roundup exposure.
Internal Monsanto documents released through prior Roundup litigation reveal that the company ghost-wrote articles published under independent scientists' names, attacked the IARC classification before and after it was released, and worked to influence the EPA's review of glyphosate. This is the same playbook Big Tobacco used — and the same kind of evidence that drove our 9-figure recoveries against cigarette manufacturers.
Trial juries have returned 9-figure verdicts against Monsanto in NHL cases — including verdicts later reduced or affirmed on appeal. In 2020, Bayer announced a settlement fund of up to $10.9 billion to resolve a portion of pending Roundup claims. Both reflect the strength of the underlying NHL link.
You may qualify for a Non-Hodgkin Lymphoma lawsuit against Monsanto and Bayer if all of the following are true:
You have been diagnosed with Non-Hodgkin Lymphoma or any specific NHL subtype — DLBCL, Follicular, Marginal Zone, Mantle Cell, Burkitt, T-cell lymphomas, or others.
You used Roundup or another glyphosate-based herbicide regularly — on a farm, in landscaping, on a golf course, in a nursery, on municipal grounds, or on your own property.
Most states give 2 to 4 years from the date of diagnosis (or, in some cases, from the date the connection between Roundup and your NHL could reasonably have been discovered).
If a family member used Roundup and died from NHL, surviving family members may be eligible to file a wrongful death lawsuit.
Herb Borroto, M.D., J.D., reviews pathology reports and oncology charts personally. Get an honest, physician-level assessment at no cost.
Get Your Free NHL Case ReviewAll major Non-Hodgkin Lymphoma subtypes can support a Roundup claim. The most common in the federal Roundup MDL are Diffuse Large B-cell Lymphoma (DLBCL) and Follicular Lymphoma. Other qualifying subtypes include Marginal Zone Lymphoma (splenic, nodal, MALT), Mantle Cell Lymphoma, Burkitt Lymphoma, Small Lymphocytic Lymphoma (the lymph-node form of CLL), Lymphoplasmacytic Lymphoma / Waldenström Macroglobulinemia, Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma (Mycosis Fungoides, Sézary syndrome), Anaplastic Large Cell Lymphoma, and Primary CNS Lymphoma. Herb Borroto, M.D., J.D., reviews pathology personally to confirm the subtype.
There is no fixed exposure threshold under the law. The strongest cases involve repeated occupational exposure — farmers, landscapers, groundskeepers, golf-course staff, nursery workers, applicators — over months or years. Heavy residential use (regular yard, garden, fence-line, or driveway spraying) can also support a case. We evaluate the duration, frequency, intensity, and protective measures (or lack of them) of your exposure.
No. A Non-Hodgkin Lymphoma case is built on the diagnosis, the treatment you went through, and the lasting effect on your life — not on your current status. Patients in complete remission, in active treatment, in relapse, and surviving family members of patients who died of NHL all may have viable claims.
Most NHL cases against Monsanto are framed primarily as failure-to-warn cases — meaning the lawsuit argues Monsanto should have warned consumers. The Alvarez Law Firm pursues failure-to-warn claims, but our lead theory is strict product liability: that Roundup, as designed, is a defective and unreasonably dangerous product that caused your NHL no matter what the label said. We have used this same defective-product framework to recover over $100 million from cigarette manufacturers, and it is the angle that puts the most pressure on Monsanto.
If you used Roundup and have been diagnosed with Non-Hodgkin Lymphoma, you may have a powerful claim against Monsanto and Bayer. We attack the case under strict product liability — the same defective-product framework we have used to take more than $100 million from Big Tobacco.
Your consultation is free, completely confidential, and comes with zero obligation. Herb Borroto, M.D., J.D., personally reviews your pathology and oncology records.
Tell us what happened. We respond within 24 hours.
Your information is confidential. Submitting this form does not create an attorney-client relationship.
